logo

KMDA

KamadaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

KMDA Profile

Kamada Ltd.

A vertically integrated global biopharmaceutical company that focused on specialty plasma-derived therapeutics

Biological Technology
12/13/1990
05/31/2013
NASDAQ Stock Exchange
374
12-31
Common stock
2 Holzman St., Weizmann Science Park, P.O Box 4081, Rehovot 7670402, Israel
Plasma-derived protein therapy companies that market existing rare combination drug products.
Kamada Ltd., was established in Israel on December 13, 1990. The company is a commercial-stage global biopharmaceutical company with a marketed product portfolio for rare and serious diseases, and is a leader in the field of specialized plasma derivation focusing on limited therapeutic alternative diseases. The company is also advancing an innovative development pipeline for areas with significant unmet medical needs. The company's strategy is focused on driving profitable growth from the company's important commercial catalysts and the company's manufacturing and development expertise in the plasma-derived and biopharmaceutical markets.